New study tracks how well alectinib keeps lung cancer from returning after surgery
NCT ID NCT06862869
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 800 Chinese patients with early-stage ALK-positive non-small-cell lung cancer who took alectinib after surgery to see how long they stay cancer-free. Researchers will collect real-world data on disease-free survival and patient characteristics. The goal is to understand how well alectinib works in everyday clinical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Alectinib
What this could lead to
If successful, this study could confirm that alectinib helps prevent lung cancer from returning after surgery in ALK-positive patients, supporting its use in routine care.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient differences. It only includes Chinese patients, so findings may not apply globally.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
RECRUITINGGuangzhou, Guangzhou, 510095, China
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, 524001, China
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, 226001, China
-
Affiliated Hospital of Zunyi Medical University
RECRUITINGZunyi, 563000, China
-
Anhui Provincial Hospital
RECRUITINGHefei, 230001, China
-
Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center
RECRUITINGShenzhen, 518127, China
-
Changzhou First People's Hospital
RECRUITINGChangzhou, 213003, China
-
Chest disease hospital of Tianjin City
RECRUITINGTianjin, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, 350014, China
-
General Hospital of Ningxia Medical University
RECRUITINGYinchuan, 750004, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, 150081, China
-
Hebei Medical University Fourth Hospital
RECRUITINGShijiazhuang, 50011, China
-
Henan Provincial Chest Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
Huai He Hospital of Henan University
RECRUITINGKaifeng, Henan, 475001, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, 410013, China
-
Huzhou Central Hospital
RECRUITINGHuzhou, 313000, China
-
Jiangmen Central Hospital
RECRUITINGJiangmen, 529030, China
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, 210000, China
-
Jiangsu Province Hospital
RECRUITINGNanjing, 210008, China
-
Lanzhou University Second Hospital
RECRUITINGLanzhou, 730030, China
-
Liaoning Provincial Cancer Hospital
RECRUITINGShengyang, 110042, China
-
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
RECRUITINGNanjing, 210008, China
-
Ningbo No.2 Hospital
RECRUITINGNingbo, 315000, China
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
-
Shandong Provincial Hospital
RECRUITINGJinan, 250021, China
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, 200433, China
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, 030013, China
-
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital
RECRUITINGChengdu, 610072, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, 317000, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, China
-
The First Affiliated Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, 830054, China
-
The First Affiliated Hospital, Chongqing Medical University
RECRUITINGChongqing, 400016, China
-
The Second Affiliated Hospital of Dalian Medical University
RECRUITINGDalian, 116027, China
-
The Second Affiliated Hospital of Xi'an Jiao Tong University
RECRUITINGXi'an, 710004, China
-
The Second Affiliated Hospital, Zhejiang University
RECRUITINGHangzhou, 310009, China
-
The Third Affiliated Hospital of Sun Yat-Sen University
RECRUITINGGuangzhou, 510630, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
RECRUITINGWuhan, 430030, China
-
Wuxi People's Hospital
RECRUITINGWuxi, 214023, China
-
Xi'an International Medical Center Hospital
RECRUITINGXi'an, 710100, China
-
Xuanwu Hospital, Capital Medical University
ACTIVE_NOT_RECRUITINGBeijing, 100053, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, 310022, China
-
Zhongshan Hospital Fudan University
RECRUITINGShanghai, 200032, China